Analyzing cancer-related substances in lung cancer patients with brain metastasis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on non-small cell lung cancer patients who have developed central nervous system metastasis. It involves collecting cerebrospinal fluid, blood samples, and tumor tissue from patients undergoing surgical procedures. The study aims to analyze the exosomes present in these samples and correlate them with clinical data to determine if these cancer cell-related substances can serve as predictive indicators for lung cancer metastasis and treatment efficacy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- A. Non-small cell lung cancer patients diagnosed with brain metastases or meningeal metastases on brain computed tomography (CT) or magnetic resonance (MRI) images.

B. Patients with non-small cell lung cancer who are about to undergo surgical brain surgery, such as brain tumor resection, lumbar abdominal drainage, Euclidean storage, or ventriculoperitoneal drainage.

Exclusion Criteria:

\- A. Non-small cell lung cancer patients without brain metastases or meningeal metastases.

B. Physical condition does not allow surgical removal of the tumor.

Where it's running

• National Taiwan University Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Abel Huang, Md
• Email: how.how0622@gmail.com
• Phone: +8860223123456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 177Lu-DTPA-omburtamab for kids with recurring medulloblastoma or brain/CNS metastases

  This study tests whether 177Lu-DTPA-omburtamab can be safely given to children and adolescents with recurrent or refractory medulloblastoma or cancer that has spread to the CNS.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07698899

• Imaging inflammation in primary and metastatic brain tumors with [C-11]-CS1P1 PET

  This trial will test a new PET tracer, [C-11]-CS1P1, in adults with primary or secondary brain tumors to see if tracer patterns of inflammation relate to MRI, treatments, and clinical outcomes.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT07462507

• Five-day radiation for children and young adults with incurable brain cancers

  This will try a shorter, five-day course of radiation for children and young adults (21 and under) with incurable central nervous system cancers to see if it is safe and improves quality of life.

  Recruiting Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT07147179

• A resource for collecting cancer data and biospecimens

  This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

  Recruiting at 42 sites University of Nebraska · Greenwood Village, Colorado and 41 other locations · NCT02012699

• Assessing Quality of Life and Outcomes for Cancer Patients Using RefleXion Radiotherapy

  This study is trying to see how different types of radiotherapy affect the quality of life and treatment outcomes for about 750 cancer patients.

  Recruiting at 5 sites RefleXion Medical · Duarte, California and 4 other locations · NCT05406167

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.